Treatment of children with a single dose a day of sustained release theophylline

Insights

A study found that children taking theophylline (Nuelin Retard) after a high-carbohydrate breakfast experienced slow absorption. Subtherapeutic theophylline levels were observed in all children, indicating potential dosing issues.

Area of Science:

  • Pharmacokinetics
  • Pediatric Pharmacology
  • Drug Absorption Studies

Background:

  • Theophylline is a bronchodilator used in managing respiratory conditions.
  • Food intake, particularly high-carbohydrate meals, can influence drug absorption.
  • Optimizing theophylline dosing in pediatric populations is crucial for effective treatment.

Purpose of the Study:

  • To evaluate the absorption profile of theophylline (Nuelin Retard) in children when administered after a carbohydrate-rich breakfast.
  • To assess serum theophylline levels over a 24-hour period following a single dose.
  • To determine if post-meal administration impacts therapeutic drug levels.

Main Methods:

  • Six pediatric patients received a single dose of theophylline (Nuelin Retard) at a median dose of 13.2 mg/kg.
  • Administration followed a large, carbohydrate-rich breakfast for four consecutive days.
  • Serum theophylline concentrations were monitored over 24 hours on the fifth day.

Main Results:

  • Theophylline absorption was characterized by a slow rate.
  • Acceptable peak to trough serum level differences were observed.
  • All children exhibited subtherapeutic theophylline levels at some point within the dosing interval.

Conclusions:

  • Administering theophylline (Nuelin Retard) after a high-carbohydrate meal in children leads to slow absorption.
  • Subtherapeutic serum concentrations achieved during the dosing interval suggest potential challenges in maintaining consistent therapeutic theophylline levels.
  • Further investigation into optimal dosing strategies and the impact of food on theophylline pharmacokinetics in pediatric patients is warranted.

Related Concept Videos

Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...